1,035 results on '"Carvalho, Edgar M."'
Search Results
2. Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection
3. Assessment of immune and clinical response in patients with mucosal leishmaniasis treated with pentavalent antimony and pentoxifylline
4. Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial
5. Profile of T and B lymphocytes in individuals resistant to Schistosoma mansoni infection
6. Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis
7. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial
8. Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis
9. In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis
10. Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis
11. MicroRNAs regulating macrophages infected with Leishmania L. (V.) Braziliensis isolated from different clinical forms of American tegumentary leishmaniasis
12. Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake
13. Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads
14. Forecasting temporal dynamics of cutaneous leishmaniasis in Northeast Brazil.
15. Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis Lesions.
16. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity
17. Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis
18. Leishmania braziliensis exosomes activate human macrophages to produce proinflammatory mediators
19. Prostaglandin e2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
20. Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy
21. IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis
22. Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
23. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals
24. Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis
25. Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial
26. NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
27. Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
28. Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
29. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
30. Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
31. Staphylococcus aureuspromotes increase IL-1 mediated immunopathology and delayed healing in cutaneous leishmaniasis
32. Regulatory T cells limit opportunistic colonization of Staphylococcus aureusto promote lesion resolution in cutaneous leishmaniasis
33. Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
34. Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies
35. Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study
36. Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
37. Evolution of erectile dysfunction in individuals infected with human T-lymphotropic virus 1: a prospective cohort study
38. The skin microbiome enhances disease through IL-1b and delays healing in cutaneous leishmaniasis patients
39. Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
40. Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)–Infected Individuals Without HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study
41. Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies
42. Tr-1-Like CD4⁺CD25⁻CD127 -/low FOXP3⁻ Cells Are the Main Source of Interleukin 10 in Patients With Cutaneous Leishmaniasis Due to Leishmania braziliensis
43. Intermediate Monocytes Contribute to Pathologic Immune Response in Leishmania braziliensis Infections
44. Blood cytokines in atopic and non‐atopic eosinophilic moderate to severe asthmatics
45. TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals
46. Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins
47. Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies
48. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis
49. Susceptibility of dendritic cells from individuals with schistosomiasis to infection by Leishmania braziliensis
50. Human Classical Monocytes Control the Intracellular Stage of Leishmania braziliensis by Reactive Oxygen Species
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.